Predictors of Postprandial Hypoglycemia After Gastric Bypass Surgery: a Retrospective Case-Control Study
Overview
Affiliations
Background: Postprandial hypoglycemia after bariatric surgery is an exigent disorder, often impacting the quality of life. Distinguishing clinically relevant hypoglycemic episodes from symptoms of other origin can be challenging. Diagnosis is demanding and often requires an extensive testing such as prolonged glucose tolerance or mixed-meal test. Therefore, we investigated whether baseline parameters of patients after gastric bypass with suspected hypoglycemia can predict the diagnosis.
Methods: We analyzed data from 35 patients after gastric bypass with suspected postprandial hypoglycemia and performed a standardized mixed-meal test. Hypoglycemia was defined by the appearance of typical symptoms, low plasma glucose, and relief of symptoms following glucose administration. Parameters that differed in patients with and without hypoglycemia during MMT were identified and evaluated for predictive precision using receiver operating characteristic (ROC) areas under the curve (AUC).
Results: Out of 35 patients, 19 (54%) developed symptomatic hypoglycemia as a result of exaggerated insulin and C-peptide release in response to the mixed-meal. Hypoglycemic patients exhibited lower glycosylated hemoglobin A1c (HbA) and higher absolute and relative weight loss from pre-surgery to study date. HbA1c and absolute weight loss alone could achieve acceptable AUCs in ROC analyses (0.76 and 0.72, respectively) but a combined score of absolute weight loss divided by HbA1c (0.78) achieved the best AUC.
Conclusions: HbA1c and weight loss differed in patients with and without symptomatic hypoglycemia during mixed-meal test. These baseline parameters could be used for screening of postprandial hypoglycemia in patients after gastric bypass and may facilitate the selection of patients requiring further evaluation.
Increased copeptin may reflect vasopressin-related metabolic changes after bariatric surgery.
Galbiati F, Becetti I, Lauze M, Aulinas A, Singhal V, Bredella M Obesity (Silver Spring). 2024; 33(2):298-307.
PMID: 39725569 PMC: 11774013. DOI: 10.1002/oby.24200.
Karimi M, Kohandel Gargari O Front Surg. 2024; 11:1449012.
PMID: 39555226 PMC: 11564166. DOI: 10.3389/fsurg.2024.1449012.
Zheng H, Sun L, Wang L, Zhao Y, Gong F, Zhu H Int J Obes (Lond). 2024; 49(1):31-42.
PMID: 39448871 DOI: 10.1038/s41366-024-01651-y.
Hazlehurst J, Khoo B, Lobato C, Ilesanmi I, Abbott S, Chan T Endocr Connect. 2024; 13(5).
PMID: 38451861 PMC: 11046333. DOI: 10.1530/EC-23-0285.
Felsenreich D, Prager G, Chiappetta S, Stier C Obes Surg. 2023; 33(11):3687-3688.
PMID: 37726563 DOI: 10.1007/s11695-023-06814-w.